Overview

Oral vs. Intravenous TXA Study Proposal: TJA

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Purpose: Examine oral and intravenous Tranexamic Acid (TXA) to determine whether or not the different routes of drug administration are equivalent in terms of post-operative reduction in hemoglobin, number of transfusions, and post-operative blood loss following TJA surgery. Hypothesis: Oral and intravenous TXA are equivalent routes of drug administration.
Phase:
N/A
Details
Lead Sponsor:
Rush University Medical Center
Treatments:
Tranexamic Acid